[Glaxo Wellcome, Germany, spends 60.000 DM for African HIV projects in Uganda and Malawi].
D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D005858:Germany; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008295:Malawi / Q000453:epidemiology; D014454:Uganda / Q000453:epidemiology
D019380:Anti-HIV Agents